Ranchi: Although the Subject Expert Committee (SEC) was formed by the drug controller General India (DGCI) approved Covaxin Bharat Biotech to investigate children between two and 18 years, the Ministry of Health, Medical Education and Family Welfare on Wednesday said that it has not received communication Official on ways to manage covid vaccines.
Speaking with Toi on Wednesday, Director of the State Health Mission Bhuvnesh Pratap Singh said, “We have not received formal intimacy from the Ministry of Health and the welfare of the United States in this matter.” Singh, however, said the inoculation drive of the State Health Department for the new recipient group would be in compliance with central guidelines and when they were accepted.
According to the estimated department, around 1.4 crore the country’s population is under the age group of 2-18 years.
Until October 11, 19.87 people were between 18 and 44 years, 13 people were between 45 and 59 years and 8.89 Senior Lakh residents had been fully immunized in the country so far.
The source in the department said that vaccinating the new age group would not be many challenges.
“We have several routine immunization sites in 24-functional districts throughout the year for child immunization programs.
These sites will be used to investigate children with covid vaccines.
In addition, we also have functional cellular vaccination vans in rural and urban areas .
They will be used too, “a senior doctor, who is associated with the state-integrated disease supervision program, said.
On Monday, Jharkhand had 1,345 session sites to manage the Covid-19 vaccine to beneficiaries over 18 years.